Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Belgian Cross-sectional Allogeneic Transplant Survivor Study

NCT02312830 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT02312830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02312830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Belgian Cross-sectional Allogeneic Transplant Survivor Study
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2014
Completion date
November 30, 2025
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hematopoietic stem cell transplantation, hematopoietic stem cell transplantation, allogeneic